NCT01402570View on ClinicalTrials.gov

Glutathione and Health With Post-Polio Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

July 31, 2013

Conditions
Post-polio SyndromePhysical ActivityDepressionPainSleep Disorders
Interventions
DIETARY_SUPPLEMENT

Glutathione

glutathione is a dietary supplement and an antioxidant. Subjects will take 1000 mg per day for three month. Each capsule contains 500 mg glutathione.

Trial Locations (1)

48108

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Penn State University

OTHER

lead

University of Michigan

OTHER

NCT01402570 - Glutathione and Health With Post-Polio Syndrome | Biotech Hunter | Biotech Hunter